Antidiabetic effects of aloe ferox and aloe greatheadii var. Davyana leaf gel extracts in a low-Dose streptozotocin diabetes rat model

South African Journal of Science

Volumn 107, Issue 7-8, 2011, Pages

  Loots, Du Toit ^a   Pieters, Marlien ^a   Islam, Md Shahidul ^a   Botes, Lisa ^a  

^a NORTH WEST UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD; COMMERCIALIZATION; DIABETES; DISEASE CONTROL; DISEASE TREATMENT; ENZYME ACTIVITY; ETHANOL; GEL; GLUCOSE; HEALTH IMPACT; HORMONE; MEDICINAL PLANT; MONOCOTYLEDON; PLANT EXTRACT; PROTEIN; RODENT;

ALOE; ALOE ARBORESCENS; ALOE FEROX; ALOE VERA; RATTUS; RATTUS NORVEGICUS;

EID: 79960660918     PISSN: 00382353     EISSN: 19967489     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Vasudevan AR, Garber AJ. Insulin resistance syndrome. A review. Minerva Endocrinol. 2005;30:101-119.
2. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Atlas. 2010;87:4-14.
3. Murugesh K, Yeligar V, Dash DK, Sengupta P, Maiti BC, Maity TK. Antidiabetic, antioxidant and antihyperlipidemic status of Heliotropium zeylanicum extract on streptozotocin-induced diabetes in rats. Biol Pharm Bull. 2006;29:2202-2205. doi:10.1248/bpb.29.2202 (Pubitemid 44690943)
4. Ducorps M, Ndong W, Jupkwo B, et al. Diabetes in Cameroon. Classification difficulties in Africa. Médecine tropicale: revue du Corps de santé colon. 1996;56:264-270.
5. Agarwal OP. Prevention of atheromatous heart disease. Angiology. 1985;36:485-492. doi:10.1177/000331978503600801, PMid:2864002 (Pubitemid 15227824)
6. Beppu HT, Nagamura Y, Fujita K. Hypoglycemic and antidiabetic effects in mice of Aloe arborescens Miller var. natalensis Berger. Phytother Res. 1993;7:S37-S42. doi:10.1002/ptr.2650070713 (Pubitemid 23106496)
7. Rajasekaran S, Sivagnaman K, Subramanian S. Antioxidant effect of Aloe vera gel extract in streptozotocin-induced diabetes in rats. Pharmacol Rep. 2005;57:90-96. PMid:15849382 (Pubitemid 40601546)
8. Elliot RB, Wasmuth H, Hill J, Songini M, Bottazzo GF, Sardinian IDDM Study Group. Diabetes and cow's milk. Lancet. 1996;348(9042):1657.
9. Botes L, Van Der Westhuizen FH, Loots DT. Phytochemical content and antioxidant capacities of two Aloe greatheadii var. davyana extracts. Molecules. 2008;13:2169-2180. doi:10.3390/molecules13092169, PMid:18830148
10. Loots DT, Van Der Westhuizen FH, Botes L. Aloe ferox leaf gel phytochemical content, antioxidant capacity, and possible health benefits. J Agric Food Chem. 2007;55:6891-6896. doi:10.1021/jf071110t, PMid:17661490 (Pubitemid 47338923)
11. Rajasekaran S, Sivagnaman K, Subramanian S. Modulatory effects of Aloe vera leaf gel extract on oxidative stress in rats treated with streptozotocin. J Pharm Pharmacol. 2005;57:241-246. doi:10.1211/0022357055416, PMid:15720789 (Pubitemid 40129093)
12. Szkudelski T. The mechanism of alloxan and streptozotocin action in b-cells of the rat pancreas. Physiol Res. 2001;50:536-546.
13. Portha B, Giroix MH, Kergoat M, Bailbe D, Blondel O, Serradas P. Animal models of non-insulin-dependent diabetes induced in the rat by experimental reduction of β cell mass. J Annu Diabetol Hotel Dieu. 1988:33-36.
14. Benzie IF, Strain JJ. Feric reducing/antioxidant power assay: Direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration. Methods Enzymol. 1999;299:15-27. doi:10.1016/S0076- 6879(99)99005-5
15. Ellis SM, Steyn HS. Practical significance (effect sizes) versus or in combination with statistical significance (p-values). Manag Dyn. 2003;12:51-53.
16. Rosenthal R, Rosnow RL, Rubin DB. Contrasts and effect sizes in behavioural research: A correlational approach. Cambridge: Cambridge University Press; 2000.
17. Beppu HT, Koike K, Shimpo T, Chihara M, Hoshino CI, Kuzuya H. Radical-scavenging effects of Aloe arborescens Miller on prevention of pancreatic islet β-cell destruction in rats. J Ethnopharmacol. 2003;89:37-45. doi:10.1016/ S0378-8741(03)00268-X
18. Islam MS, Loots DT. Experimental rodent models of type 2 diabetes: A review. Methods Find Exp Clin Pharmacol. 2009;31:249-261. doi:10.1358/ mf.2009.31.4.1362513, PMid:19557203
19. Brownlee M. The pathobiology of diabetic complications: A unifying mechanism. Diabetes. 2005;54:1615-1625. doi:10.2337/diabetes.54.6.1615, PMid:15919781 (Pubitemid 40770750)
20. Grove J, Daly AK, Bassendine MF, Day CP. Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitis. Hepatology. 1997;26:143-146. doi:10.1002/hep.510260119, PMid:9214463 (Pubitemid 27280318)
21. Brownlee M. A radical explanation for glucose-induced β cell dysfunction. J Clin Invest. 2003;112:1788-1790. doi:10.1172/JCI20501, PMid:14679173, PMCid:297003
22. Burcelin R, Eddouks M, Maury J, Kande J, Assan R, Girard J. Excessive glucose production, rather than insulin resistance, accounts for hyperglycemia in recent-onset streptozotocin-diabetic rats. Diabetologia. 1995;38:283-290. doi:10.1007/BF00400632, PMid:7758874
23. Garcia-Compean D, Jaquez-Quintan JO, Maldonado-Gaza H. Hepatogenous diabetes. Current reviews of an ancient problem. Ann Hepatol. 2009;8:13-20. PMid:19221528
24. Satriano J, Vallon V. Primary kidney growth and its consequences at the onset of diabetes mellitus. Amino Acids. 2006;31:1-9. doi:10.1007/s00726- 006-0326-x, PMid:16733619 (Pubitemid 44086393)
25. Valentovic MA, Alejandro N, Carpenter B, Brown A, Ramos K. Streptozotocin (STZ) diabetes enhances benzo(alpha)pyrene induced renal injury in Sprague Dawley rats. Toxicol Lett. 2006;164:214-220. doi:10.1016/j.toxlet.2005.12.009, PMid:16460892
26. Lugman W, Abdella N, Moro M. Serum fructosamine concentration as measure of blood glucose control in insulin dependent diabetes. Br Med J. 1985;290:1075-1076. doi:10.1136/bmj.290.6474.1075-a, PMid:3921112, PMCid:1418361
27. Jiao S, Matsuzawa Y, Matsubara K, et al. Increased activity of intestinal acyl- CoA:cholesterol acyltransferase in rats with streptozotocin-induced diabetes and restoration with insulin supplementation. Diabetes. 1988;37:342-346. doi:10.2337/diabetes.37.3.342, PMid:2967215 (Pubitemid 18065062)
28. Kusunoki J, Aragane K, Kitamine T, et al. Postprandial hyperlipidemia in streptozotocin-induced diabetic rats is due to abnormal increase in intestinal acyl coenzyme A:cholesterol acyltransferase activity. Arterioscler Thromb Vasc Biol. 2000;20:171-178. PMid:10634814 (Pubitemid 30048360)
29. Krauss RM. Lipids and lipoproteins in patients with type 2 diabetes. Diabetes Care. 2004;27:1496-1504. doi:10.2337/diacare.27.6.1496, PMid:15161808 (Pubitemid 38680002)